About the Desmoid Tumor Session
Desmoid tumors, though rare, present unique challenges in cancer research due to their unpredictable behavior. These tumors, also known as desmoid-type fibromatosis, are noncancerous growths that arise from connective tissue. While they do not metastasize, they can invade nearby tissues and organs, causing significant morbidity. Current research aims to understand the molecular mechanisms driving their growth and develop targeted therapies to control their progression. Treatment typically involves a multidisciplinary approach, including surgery, radiation, and systemic therapies. However, recurrence rates remain high, underscoring the need for innovative treatment strategies. Collaborative efforts between researchers, clinicians, and patients are crucial in advancing our understanding of desmoid tumors and improving patient outcomes.
Topics Covered in Desmoid Tumor
Beta-Catenin Mutations
Familial Polyposis
Active Surveillance
Gamma-Secretase Inhibitors
Cryoablation
Intra-Abdominal Disease
Related Scientific Sessions at CIOC 2027
Why Attend the Desmoid Tumor Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Desmoid Tumor work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Desmoid Tumor research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Desmoid Tumor track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Desmoid Tumor Conference 2027 — FAQs
What is the Desmoid Tumor track at CIOC 2027?
The Desmoid Tumor track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Desmoid Tumor. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Desmoid Tumor sessions?
Cancer researchers and clinicians, educators and students with an interest in Desmoid Tumor are all welcome — whether presenting or attending.
Can I present my research in the Desmoid Tumor track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Desmoid Tumor sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Desmoid Tumor track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.